- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Suven Life Sciences Limited — Others, 08-11-2024: Monitoring Agency Report
08-11-2024 | 05:52 pm
08-11-2024 | 05:52 pm
Suven Life Sciences Limited has released a report from CRISIL Ratings regarding the utilization of proceeds from its Rights Issue for the quarter ending September 30, 2024. The report indicates no deviations from the planned utilization of funds, which include expenditures on pharmaceutical research, repayment of inter-corporate deposits, and general corporate purposes. All funds are aligned with the objectives stated in the offer document.
No comments yet. Be the first to comment!